Subscribe to Jiayan Chen's Posts
Jiayan Chen counsels clients on a range of regulatory and strategic issues that arise in the context of biomedical innovation and data sharing initiatives. She also has extensive experience advising life sciences companies and their collaborators on state and federal “Sunshine” and gift ban requirements. Read Jiayan Chen's full bio.
By Jiayan Chen and Brian Boyle on Sep 21, 2021
Posted In Digital Health, Employee Benefits, Health and Welfare Plans, Privacy and Data Security
Telemedicine in the United States is facing an important crossroads. While telehealth services have demonstrated their value as an integral part of care delivery, federal and state waivers instituted during the COVID-19 pandemic are likely to expire soon. As lawmakers and agency officials consider updated or expanded digital health rules, regulators are expected to intensify...
By Vernessa T. Pollard, Sarah T. Hogan, Scott Weinstein, Ryan Marcus, Michael Ryan, Lisa Schmitz Mazur, Jiayan Chen, Jennifer S. Geetter, Dale C. Van Demark, Bernadette M. Broccolo and McDermott Will & Emery on Feb 8, 2018
Posted In Health and Welfare Plans, Privacy and Data Security
Throughout 2017, the health care and life sciences industries experienced a widespread proliferation of digital health innovation that presents challenges to traditional notions of health care delivery and payment as well as product research, development and commercialization for both long-standing and new stakeholders. At the same time, lawmakers and regulators made meaningful progress toward modernizing...